Event 27 May. 2021
Curtis Partners Speak at the Fifth ICC Africa Conference on International Arbitration
Event 19 May. 2021
Partners Timi Balogun and Marc Hammerson to speak on Nigeria's update to its oil and gas legislation at webinar hosted by AIPN
Event 23 Apr. 2021
Partner Borzu Sabahi to speak on Damages, Enforcement and Annulment of Arbitral Awards at Executive Training Program hosted by the Government of India and the Indian Institute of Foreign Trade
Event 31 Mar. 2021
Claudia Frutos-Peterson Speaks at Mumbai Centre for International Arbitration’s India ADR Week
News 13 May. 2021
Curtis New York Partner Leads Brussels Expansion
News 22 Apr. 2021
Curtis Practices and Attorneys Gain Recognition in the Legal 500 EMEA 2021
Event 16 Jun. 2021
Partners Luciana Ricart and Fernando Tupa Speak at Workshop on Hearings in International Arbitration in The Arbanza School of Arbitration Course
Event 13 May. 2021
Curtis Partners Speak about How Chapter 11 Impacts Mexican Companies
Event 02 Jun. 2021
Co-Head of the Tax Department, Marco Blanco and Tax Partner, Olga Beloded teach a three day course on International Taxation as part of The Executive LLM Program conducted by The DIFC and University of Paris II – Assas in Dubai.
News 05 Feb. 2021
London partners Charles Buderi and Luciana Ricart part of team securing absolute victory for the UAE at the International Court of Justice
Event 27 Apr. 2021
Partner Gabriela Alvarez Avila speaks on Recent Developments in International Commercial & Investment Arbitration in North America
News 31 Mar. 2021
Partner Simon Batifort Elected to the Executive Council of the American Society of International Law
Client Alert 06 Apr. 2021
U.S. Insight: Update on Virtual Notarization (Executive Order 202.7) During the COVID-19 (Coronavirus) Pandemic (Updated: April 6, 2021)
U.S. Insight: Update on Virtual Witnessing (New York Executive Order 202.14) During The COVID-19 (Coronavirus) Pandemic (Updated: April 6, 2021)
Companies operating in the pharmaceutical and related sectors such as healthcare must grapple with cutting-edge scientific development as well as shifting regulatory regimes, which complicate corporate mergers and acquisitions, managing intellectual property portfolios and patents, and litigating disputes. The ethical dimension makes it imperative to have the right legal advice.
Curtis provides a wide range of legal services to clients in the pharmaceutical sector. Our pharmaceutical attorneys advise manufacturers, funds and institutions on transactions and disputes involving branded and generic pharmaceuticals, biotechnology equipment, clinical systems, nanotechnology, medical software and prescription drugs, drug delivery and drug packaging.
We have advised on a diverse range of mergers and acquisitions and other transactions.
The wider Curtis team includes experts in the field of healthcare compliance, as well as former medical doctors and lawyers with experience in pharmaceutical patent and regulatory (Hatch-Waxman) litigation in the U.S.
This has enabled Curtis to develop a range of experience in the pharmaceutical sector, ranging from healthcare issues to compliance and specialist intellectual property. Our healthcare attorneys have also advised on the development and financing of healthcare infrastructure projects such as hospitals in many countries, by way of PPI as well as traditional project finance and Islamic finance.
Intellectual Property Litigation
Commercial Disputes - Litigation
Legal 500 USA, 2019
Legal 500: USA M&A(Middle-Market) 2017
Legal 500 USA 2019